Additionally, GSK plans to establish a new vaccines drug substance plant at the site, dedicated to manufacturing products based on the company’s novel MAPS ... for global supply chain, in ...

President Global Supply Chain, GSK said. “We’re grateful for the support of local and state officials, who made this project possible, and we are excited to expand upon the important work ...

The former facility will manufacture products based on Multiple Antigen Presenting System (MAPS) technology ... system monitoring. GSK’s global supply chain president Regis Simard said ...

The Q3 presentation was sent to our distribution list by e-mail and you can also find it on gsk.com. Please turn ... investments to drive future supply chain efficiencies, with additional charges ...

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of the UK budget announcement later, while GSK hurt the FTSE ... disruption in its supply chain and continued ...

Dr. Robert Brooks explores why pharma must map its supply chains in emerging markets. In the last few years we have seen a whole raft of supply chain disruptions hit the pharmaceutical sector ...

Maxeon also took the unprecedented step of publishing detailed supply chain maps on its website that disclosed full supply chain details including vendors and manufacturing locations from quartz ...

The FDF represents more than a thousand businesses across the food and drink industry in the U.K. The organization unveiled its "Ambition 2030" program on October 23, in hopes of bringing its supply ...

The site will also house a drug substance facility to manufacture vaccines based on GSK’s Multiple Antigen Presenting System (MAPS) technology ... President Global Supply Chain, GSK, in a public ...

Maxeon also took the unprecedented step of publishing detailed supply chain maps on its website that disclosed full supply chain details including vendors and manufacturing locations from quartz ...